# Lon S. Schneider

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lon-s-schneider/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,015 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 86 |
| i10-index | 287 |
| Last Known Institution | University of Southern California |
| OpenAlex ID | https://openalex.org/A5059020389 |
| ORCID iD | 0000-0002-4636-6150 |
| Works | 509 |

## Researcher papers

Showing 12 of 16.

- [Dementia prevention, intervention, and care: 2020 report of the Lancet Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2020-report-of-the-lancet-commission/)
- [Dementia prevention, intervention, and care](https://scholariq.org/papers/dementia-prevention-intervention-and-care/)
- [Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria](https://scholariq.org/papers/advancing-research-diagnostic-criteria-for-alzheimer-s-disease-the-iwg-2/)
- [Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2024-report-of-the-lancet-standing/)
- [Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria](https://scholariq.org/papers/preclinical-alzheimer-s-disease-definition-natural-history-and-diagnostic/)
- [Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction](https://scholariq.org/papers/blood-brain-barrier-breakdown-is-an-early-biomarker-of-human-cognitive/)
- [Defeating Alzheimer's disease and other dementias: a priority for European science and society](https://scholariq.org/papers/defeating-alzheimer-s-disease-and-other-dementias-a-priority-for-european/)
- [Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease](https://scholariq.org/papers/effectiveness-of-atypical-antipsychotic-drugs-in-patients-with-alzheimer-s/)
- [Effect of Citalopram on Agitation in Alzheimer Disease](https://scholariq.org/papers/effect-of-citalopram-on-agitation-in-alzheimer-disease/)
- [Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future](https://scholariq.org/papers/neuropsychiatric-symptoms-in-alzheimer-s-disease-past-progress-and-anticipation/)
- [Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images](https://scholariq.org/papers/multimodal-and-multiscale-deep-neural-networks-for-the-early-diagnosis-of/)
- [Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology](https://scholariq.org/papers/basal-forebrain-degeneration-precedes-and-predicts-the-cortical-spread-of/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

## Researcher university

- [University of Southern California](https://scholariq.org/institutions/university-of-southern-california/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.